Suppressing an Anti-Inflammatory Cytokine Reveals a Strong Age-Dependent Survival Cost in Mice

Abstract

BackgroundThe central paradigm of ecological immunology postulates that selection acts on immunity as to minimize its cost/benefit ratio. Costs of immunity may arise because the energetic requirements of the immune response divert resources that are no longer available for other vital functions. In addition to these resource-based costs, mis-directed or over-reacting immune responses can be particularly harmful for the host. In spite of the potential importance of immunopathology, most studies dealing with the evolution of the immune response have neglected such non resource-based costs. To keep the immune response under control, hosts have evolved regulatory pathways that should be considered when studying the target of the selection pressures acting on immunity. Indeed, variation in regulation may strongly modulate the negative outcome of immune activation, with potentially important fitness consequences.Methodology/Principal FindingsHere, we experimentally assessed the survival costs of reduced immune regulation by inhibiting an anti-inflammatory cytokine (IL-10) with anti-IL-10 receptor antibodies (anti-IL-10R) in mice that were either exposed to a mild inflammation or kept as control. The experiment was performed on young (3 months) and old (15 months) individuals, as to further assess the age-dependent cost of suppressing immune regulation. IL-10 inhibition induced high mortality in old mice exposed to the mild inflammatory insult, whereas no mortality was observed in young mice. However, young mice experienced a transitory lost in body mass when injected with the anti-IL-10R antibodies, showing that the treatment was to a lesser extent also costly for young individuals.ConclusionsThese results suggest a major role of immune regulation that deserves attention when investigating the evolution of immunity, and indicate that the capacity to down-regulate the inflammatory response is crucial for late survival and longevity.

Peripheral tumors alter neuroinflammatory responses to lipopolysaccharide in female rats

“…Alternatively, the transient nature of the exaggerated neuroinflammatory rise in tumor-bearing rats may be a consequence of disease-burdened metabolic constraints. Inflammation, and in particular, excessive inflammation, requires significant energetic resources (Belloni et al, 2010), which may be unsustainable in rats that are simultaneously supporting the growth of a tumor.…”

Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment

“…As the majority of cancer patients are elderly, these results imply that systemically blocking the IL-10 receptor should be evaluated carefully. 38…”

The CCL5/CCR5 axis promotes interleukin‐6 production in human synovial fibroblasts

“…IL‐10 inhibition caused high mortality in older animals, whereas no mortality was observed in young animals. As the majority of cancer patients are elderly, these results imply that systemically blocking the IL‐10 receptor should be evaluated carefully 38…”

“…Immunologists using animal models are often less focused on side effects than on efficacy. However, more researchers are starting to become aware that in order for preclinical animal models to be more representative to the human situation, lower doses of immune stimulating agents should be used, and toxic side effects in animal models should be meticulously analyzed 38, 41, 42…”